Beclometasoni dipropionas, Formoteroli fumaras dihydricus
Medicinal product name | Foster 100/6 micrograms per actuation pressurised inhalation solution |
||||||
---|---|---|---|---|---|---|---|
Pharmaceutical form | Pressurised inhalation, solution | ||||||
Strength | 100/6 micrograms per actuation | ||||||
Information from the MAH on shortages | No information on expected shortages | ||||||
Availability of medicinal product |
|
||||||
Legal status | NHS Reimbursed medicines |
Prescription (Pr.)||||||
Package leaflet | 02-11-2023 | ||||||
Summary of product characteristics | 02-11-2023 | ||||||
ATC code | R03AK08 – Drugs for obstructive airway diseases | ||||||
Information for Marketing authorisation holders | View |
Additional information regarding the use for persons aged 75+
If used as "DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES" | ||
---|---|---|
Substance | Class | Comment |
Beclometasoni dipropionas | A | Suitable for older adults. Consider possible systemic adverse effects with high doses. |
Formoteroli fumaras dihydricus | A | Suitable for older adults. Potentiates sympathomimetic effects. May cause hypokalaemia. |
Medicinal products (3)
Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
---|---|---|---|---|---|---|
Is available (according to the information provided by wholesalers) (2263 containers) |
Recipe Plus, Tamro, Magnum Medical, Euroaptieka, Oribalt Rīga |
N120: 120 × 1 (100 µg/6 µg) |
Inhaler |
€ 48.35 * |
08-0224-01 |
Labelling text Jan 31, 2023 Labelling text Jan 31, 2023 |
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N180: 180 × 1 (100 µg/6 µg) |
Inhaler | 08-0224-02 |
Labelling text Jan 31, 2023 Labelling text Jan 31, 2023 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N240: 120 × 2 (100 µg/6 µg) |
Inhaler | 08-0224-03 |
Labelling text Jan 31, 2023 Labelling text Jan 31, 2023 |
Registration information
Marketing authorisation No. | 08-0224 |
---|---|
Date of authorisation | Sep 25, 2008 |
Marketing authorisation holder, country | Chiesi Pharmaceuticals GmbH, Austria |